"The global electric vehicle market at $39.8 billion in

New Post Public Reply Private Reply Replies (0) Message Board
Goreman
93
"The global electric vehicle market at $39.8 billion in 2018 is projected to reach $1.5 trillion by 2025. Units sales are anticipated to reach 97 million vehicles worldwide by 2025. - Wintergreen Research Inc.


Ideanomics Reported Q2 Revenue of $4.7 million and Forecasts Quarter-over-Quarter EV Sales Growth in Q3 and Q4 2020


September 2020 - There are many investment opportunities for investors who want to capitalize on the growing EV industry. Leading the way is Tesla (Nasdaq-TSLA) who has seen tremendous amount of market attention and share appreciation in 2020. One company that is doing creative business in the EV sector is Ideanomics Inc. (Nasdaq-IDEX).

Ideanomics current focus is on commercial electric vehicle acquisitions and assisting commercial fleet operators with transitioning from their gas & diesel fleets through a procurement, lease financing, insurance, government rebates and subsidies, battery purchases and prepaid energy supply process and therefore providing “End to End” EV services.

Ideanomics names their platform “Sales to Financing to Charging” (S2F2C) business model.

Commercial fleet vehicles include heavy- duty trucks, logistic vehicles, buses, taxis, couriers, and the like.

China currently has an estimated 11 million heavy- duty trucks and off-road vehicles, 14 million delivery vehicles, 1.6 million city and tourist buses, 1.2 million taxis/ride-sharing vehicles, and more than 100,000 gas stations which are going to be converted into battery charging stations.

Ideanomics is doing business with these Chinese commercial fleet operators and is providing EV acquisitions, wholesale and pre-paid electricity or discounted access to Ideanomics’ preferred partner charging stations, which will be a recurring revenue stream for the Company.

Ideanomics established a new division named the Medici Motor Works to manufacture and sell EV Trucks, Vans & Bus into North America and other parts of the world.

To operate successfully in China Ideanomics has Chinese American entrepreneur billionaire Dr. Bruno Wu, who is the Chairman of Ideanomics who owns a 19% equity stake in the Company. Dr. Bruno Wu’s wife, Yang Lan, is a high-profile Chinese media personality who is often referred to as the Oprah Winfrey of China.

Vice Chairman Mr. Shane McMahon owns 4% and is from the multi billionaire American McMahon family which owns World Wresting Entertainment. (WWE)

Ideanomics recently reported Q2 revenue of $4.7 million, up from $378,000 in Q1. The Company ended the quarter with reducing its debt by ~ 50% and US$36.4 million in cash, which it says could be used for acquisitions later this year. IDEX called the second quarter its best mobile energy results since moving into electric vehicle sales. Further, Ideanomics forecasts quarter-over-quarter growth in Q3 and Q4 2020.

Another important component of IDEX’s future growth will come from its 51% majority ownership of Treeletrik, an approved electric vehicles manufacturer and distributor for Malaysia. As Treeletrik expands its product line to electric vehicle E bikes, mopeds, cars, and light rail cars and serving the 650 million people in the ASEAN region which includes Malaysia, Cambodia, Vietnam, Philippines, Indonesia, Laos, Singapore, and Brunei.

As the global EV sector continues its current growth trajectory with China being the largest EV market in the world, making up 57% of the global market as of April 2020; along with a market cap of $250 M and strong institutional and fund ownership with shareholders like BlackRock, Vanguard, State Street, Charles Schwab, Barclay's, and Fidelity, Ideanomics is well positioned to take advantage of this growth and capitalize on the EV market and provide investors with an opportunity for significant ROI.


Ideanomics Inc. (Nasdaq-IDEX) End to End EV Solutions


Revenue of $4.7 million Q2 and Expects Quarter-Over-Quarter Growth in Q3 and Q4 2020



557 EV Units Processed at MEG EV Center in Qingdao for July & August an Increase from Q 2


China is already the largest EV market in the world, making up 57% of the global market as of April 2020.


Ideanomics reported $4.7M Q2 in revenues in August. Most of the performance and growth of the company was brought about by the EV sales business of MEG, a Chinese subsidiary of Ideanomics.


Proactive Investor CEO Interview

Sept 17, 2020


https://www.youtube.com/watch?v=NVsrMFo4uec


Ideanomics Revenue Streams


Commercial EV Sales

Lease Financing – Sales

Qingdao EV Hub Sales

Medici Motor Works Trucks, Vans & Bus Sales

Treeletrik E Bike Sales




Energy Sales

Prepaid Electricity Commercial Fleet Sales

EV Fast Charging Network Sales

5G Smart City Energy Sales

Electricity Debit Card Sales (with China’s Union Pay)




Share Structure August 4, 2020


Market Cap $389,177,181

Outstanding Shares 237,303,159

Restricted Shares 73,424,144

Unrestricted Shares 163,531,862

52 Week Hi-lo $3.98-$0.27


Major Institutional Ownership: BlackRock, Vanguard, State Street, Charles Schwab, Barclay's, Fidelity


Symbol: IDEX: Nasdaq

www.ideanomics.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 2

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Insightful Findings on gMG Treatments by UCB at AANEM 2024

Updated Category News Views 127

UCB Highlights Innovations in Generalized Myasthenia Gravis Treatments at AANEM 2024 UCB, a prominent global biopharmaceutical company, is gearing up to present its latest findings in the management of generalized myasthenia gravis (gMG) at the upcoming American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) meeting. The event, which will also feature...

Continue Reading
Lysander Funds Shares New Distributions Estimates for ETFs

Updated Category News Views 131

Lysander Funds Shares New Distributions Estimates Lysander Funds Limited recently made an announcement about the anticipated cash distributions for December 2024 for their exchange-traded funds (ETFs). The focus is on three notable ETFs: Lysander-Slater Preferred Share ActivETF, Lysander-Canso Corporate Treasury ActivETF, and Lysander-Canso Floating Rate ActivETF. Each of...

Continue Reading
Empowering Girls: Pace Center's Initiatives for Growth

Updated Category News Views 350

Introduction to the Capital Campaign Pace Center for Girls Hillsborough is excited to announce its capital campaign aimed at expanding its capacity and enhancing the support provided to girls in the community. Through dedicated efforts such as education, counseling, and training, this campaign signifies a crucial step towards bettering the future for girls in Hillsborough...

Continue Reading
Bank of America Sees Growth in Loans, Deposits Amid Profit Rise

Updated Category News Views 284

Bank of America Reports Increased Earnings and Efficiency Bank of America Corp (NASDAQ: BAC) has announced strong financial results for the second quarter, showcasing impressive growth in loans, deposits, and overall profitability. The bank reported a net income of $7.1 billion, a slight increase from $6.9 billion the previous year, along with an earnings per share (EPS)...

Continue Reading
Investigating Manitex International: A Closer Look at MNTX

Updated Category News Views 72

Examining Fair Treatment for Manitex International Shareholders Ademi LLP has launched an investigation into Manitex International, Inc. (NASDAQ: MNTX) due to concerns about possible breaches of fiduciary duty related to its recent transaction with Tadano. This investigation raises important questions about whether shareholders are being treated fairly in the financial...

Continue Reading